Scholars@Duke

A phase II study of estramustine (E), docetaxel (D) and exisulind in hormonerefractory prostate cancer (HRPC): Initial results of CALGB 90004.

Publication ,  Conference
Dawson, NA; Halabi, S; Biggs, DD; Ou, SS; Kelly, WK; Small, EJ
Published in: JOURNAL OF CLINICAL ONCOLOGY
June 1, 2005
Link to item

Duke Scholars

Susan Halabi
Author Susan Halabi Biostatistics & Bioinformatics, Division of Biostatistics

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

June 1, 2005

Volume

23

Issue

16

Start / End Page

415S / 415S

Location

Orlando, FL

Publisher

AMER SOC CLINICAL ONCOLOGY

Conference Name

41st Annual Meeting of the American-Society-of-Clinical-Oncology

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Dawson, N. A., Halabi, S., Biggs, D. D., Ou, S. S., Kelly, W. K., & Small, E. J. (2005). A phase II study of estramustine (E), docetaxel (D) and exisulind in hormonerefractory prostate cancer (HRPC): Initial results of CALGB 90004. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 23, pp. 415S-415S). Orlando, FL: AMER SOC CLINICAL ONCOLOGY.
Dawson, N. A., S. Halabi, D. D. Biggs, S. S. Ou, W. K. Kelly, and E. J. Small. “A phase II study of estramustine (E), docetaxel (D) and exisulind in hormonerefractory prostate cancer (HRPC): Initial results of CALGB 90004.” In JOURNAL OF CLINICAL ONCOLOGY, 23:415S-415S. AMER SOC CLINICAL ONCOLOGY, 2005.
Dawson NA, Halabi S, Biggs DD, Ou SS, Kelly WK, Small EJ. A phase II study of estramustine (E), docetaxel (D) and exisulind in hormonerefractory prostate cancer (HRPC): Initial results of CALGB 90004. In: JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2005. p. 415S-415S.
Dawson, N. A., et al. “A phase II study of estramustine (E), docetaxel (D) and exisulind in hormonerefractory prostate cancer (HRPC): Initial results of CALGB 90004.” JOURNAL OF CLINICAL ONCOLOGY, vol. 23, no. 16, AMER SOC CLINICAL ONCOLOGY, 2005, pp. 415S-415S.
Dawson NA, Halabi S, Biggs DD, Ou SS, Kelly WK, Small EJ. A phase II study of estramustine (E), docetaxel (D) and exisulind in hormonerefractory prostate cancer (HRPC): Initial results of CALGB 90004. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2005. p. 415S-415S.

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

June 1, 2005

Volume

23

Issue

16

Start / End Page

415S / 415S

Location

Orlando, FL

Publisher

AMER SOC CLINICAL ONCOLOGY

Conference Name

41st Annual Meeting of the American-Society-of-Clinical-Oncology

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences